Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shapiro, M.
Right arrow Articles by McLean, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shapiro, M.
Right arrow Articles by McLean, G.

Chest, Vol 94, 1225-1231, Copyright © 1988 by American College of Chest Physicians

ARTICLES

Severe hemoptysis associated with pulmonary aspergilloma. Percutaneous intracavitary treatment

MJ Shapiro, SM Albelda, RL Mayock and GK McLean
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia 19104.

Surgical therapy for massive hemoptysis associated with pulmonary aspergilloma carries a high morbidity and mortality in patients with limited pulmonary reserve. Bronchial artery embolization has proven ineffective in treating and in preventing recurrent episodes of hemoptysis in this group of patients. Over a four-and-one-half year period, we have successfully treated six episodes of acute hemoptysis in four patients using a percutaneously placed catheter and intracavitary instillation of amphotericin B, N-acetylcysteine, and aminocaproic acid. Advantages of this method of treatment for patients with severely compromised pulmonary reserve include: (1) no further loss of lung function; (2) ease and rapidity of catheter insertion; (3) prompt response to treatment; (4) relatively short hospitalization; and (5) ability to repeat the procedure in the same or another cavity if necessary.


This article has been cited by other articles:


Home page
 ThoraxHome page
J L Lordan, A Gascoigne, and P A Corris
The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis
Thorax, September 1, 2003; 58(9): 814 - 819.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
E. Hakanson, I. E. Konstantinov, S.-G. Fransson, and R. Svedjeholm
Management of life-threatening haemoptysis
Br. J. Anaesth., February 1, 2002; 88(2): 291 - 295.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Chest Physicians.